Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Trop ; 256: 107263, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38768696

ABSTRACT

Toxoplasma gondii, a parasite infecting around one-third of the global population, has been linked to neurological disorders like schizophrenia. Abnormal dopamine levels are linked to the pathophysiology of schizophrenia, but their association remains unclear. This study aimed to investigate the relationship between T. gondii seroprevalence and dopamine serum levels in schizophrenic patients in Egypt. This case-control study included 93 patients diagnosed with schizophrenia and 93 individuals as controls. T. gondii seroprevalence was determined using an enzyme-linked immunosorbent assay (ELISA). Dopamine serum levels were measured using ELISA. Sociodemographic and clinical characteristics were also collected. The study found a higher prevalence of T. gondii IgG antibodies in patients with schizophrenia (68 %) compared to controls (46.2 %). Contact with cats, sausage consumption, and undercooked meat were identified as possible risk factors associated with T. gondii infection. The mean level of serum dopamine was significantly (P < 0.001) higher in patients with schizophrenia (115.3 Pg/ml ±31.8) compared to the control group (75.02 Pg/ml ±26.5). The study found that schizophrenic patients with T. gondii seropositivity had significantly higher dopamine serum levels (mean=145.2 ± 32.1 pg/ml) than those without T. gondii seropositivity (mean=122.5 ± 29.7 pg/ml) (p = 0.001). Logistic regression analysis revealed that T. gondii seropositivity was a significant predictor of increased dopamine serum levels in schizophrenic patients (odds ratio=3.4, 95 % confidence interval=1.8-6.4, p < 0.001). The study suggests that T. gondii seroprevalence may increase dopamine serum levels in Egyptian schizophrenic patients, potentially contributing to dopamine dysregulation in schizophrenia, but further research is needed to confirm these findings and investigate the underlying mechanisms.


Subject(s)
Antibodies, Protozoan , Dopamine , Schizophrenia , Toxoplasmosis , Humans , Schizophrenia/blood , Schizophrenia/epidemiology , Schizophrenia/parasitology , Egypt/epidemiology , Toxoplasmosis/epidemiology , Toxoplasmosis/blood , Male , Female , Dopamine/blood , Case-Control Studies , Adult , Antibodies, Protozoan/blood , Seroepidemiologic Studies , Middle Aged , Immunoglobulin G/blood , Toxoplasma/immunology , Enzyme-Linked Immunosorbent Assay , Young Adult , Risk Factors , Animals
SELECTION OF CITATIONS
SEARCH DETAIL
...